Epidemiological and pathophysiological evidence supporting links between obstructive sleep apnoea and Type 2 diabetes mellitus.

Author: Chuen Peng LEE ¹ ; Clete A KUSHIDA ² ; John Arputhan ABISHEGANADEN ¹
Author Information

1. Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
2. Stanford Sleep Medicine Center, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, California, United States.
Publication Type:Journal Article
Keywords: diabetes mellitus; obstructive sleep apnoea; pathophysiology; sleep-disordered breathing
MeSH: Adult; Aged; Continuous Positive Airway Pressure; Diabetes Mellitus, Type 2; complications; epidemiology; physiopathology; Female; Humans; Male; Middle Aged; Sleep Apnea, Obstructive; complications; epidemiology; physiopathology; therapy; Young Adult
From:Singapore medical journal 2019;60(2):54-56
CountrySingapore
Language:English
Abstract: Obstructive sleep apnoea (OSA) and Type 2 diabetes mellitus (T2DM) are common diseases. The global prevalence of OSA is between 2% and 7% in general population cohorts. The worldwide prevalence of T2DM among adults (aged 20-79 years) was estimated to be 6.4%. The concurrent presence of OSA and T2DM can be expected in the same patient, given their high prevalence and similar predisposition. We reviewed the overlapping pathophysiology of OSA and T2DM in this article.